References
Nulman I, Laslo D, Koren G. Treatment of epilepsy in pregnancy. Drugs 1999 Apr; 57(4): 535–44
Leppik IE, Wolff D, Purves S. Treatment of epilepsy in women of childbearing potential: issues in management. CNS Drugs 1999 Mar; 11(3): 191–206
Morrell MJ. Hormones, reproductive health and epilepsy. In: Wyllie E, editor. The treatment of epilepsy: principles and practice, 2nd ed. Baltimore (MD): Williams & Wilkins, 1997: 179–87
Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975; 16: 99–110
British National Formulary. No. 38. London: The Pharmaceutical Press, 1999 Sep: 215-24
Delgado-Escueta AV, Janz D. Consensus guidelines: preconception counselling, management, and care of the pregnant woman with epilepsy. Neurology 1992; 42(Suppl. 5): 149–60
Lindhout D, Hoppener RJ, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984; 25(1): 77–83
Kaneko S, Otani K, Fukushima Y, et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia 1988; 29: 459–67
Sophocles AM, Brozovich EM. Birth control failure among patients with unwanted pregnancies: 1982–1984. J Fam Pract 1986: 22(1): 45–8
Moslet U, Hansen ES. A review of vitamin K, epilepsy and pregnancy. Acta Neurol Scand 1992; 85(1): 39–43
Yerby MS. Pregnancy and epilepsy. Epilepsia 1991; 32 Suppl. 6: S51–9
Rights and permissions
About this article
Cite this article
With proper care, successful pregnancy likely in women with epilepsy. Drugs Ther. Perspect 15, 5–8 (2000). https://doi.org/10.2165/00042310-200015040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200015040-00002